The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Cell Origins of High-Grade Serous Ovarian Cancer
Open accessAbstract
High-grade serous ovarian cancer, also known as high-grade serous carcinoma (HGSC), is the most common and deadliest type of ovarian cancer. HGSC appears to arise from the ovary, fallopian tube, or peritoneum. As most HGSC cases present with widespread peritoneal metastases, it is often not clear where HGSC truly originates. Traditionally, the ovarian surface epithelium (OSE) was long believed to be the origin of HGSC. Since the late 1990s, the fallopian tube epithelium has emerged as a potential primary origin of HGSC. Particularly, serous tubal intraepithelial carcinoma (STIC), a noninvasive tumor lesion formed preferentially in the distal fallopian tube epithelium, was proposed as a precursor for HGSC. It was hypothesized that STIC lesions would progress, over time, to malignant and metastatic HGSC, arising from the fallopian tube or after implanting on the ovary or peritoneum. Many clinical studies and several mouse models support the fallopian tube STIC origin of HGSC. Current evidence indicates that STIC may serve as a precursor for HGSC in high-risk women carrying germline BRCA1 or 2 mutations. Yet not all STIC lesions appear to progress to clinical HGSCs, nor would all HGSCs arise from STIC lesions, even in high-risk women. Moreover, the clinical importance of STIC remains less clear in women in the general population, in which 85–90% of all HGSCs arise. Recently, increasing attention has been brought to the possibility that many potential precursor or premalignant lesions, though composed of microscopically—and genetically—cancerous cells, do not advance to malignant tumors or lethal malignancies. Hence, rigorous causal evidence would be crucial to establish that STIC is a bona fide premalignant lesion for metastatic HGSC. While not all STICs may transform into malignant tumors, these lesions are clearly associated with increased risk for HGSC. Identification of the molecular characteristics of STICs that predict their malignant potential and clinical behavior would bolster the clinical importance of STIC. Also, as STIC lesions alone cannot account for all HGSCs, other potential cellular origins of HGSC need to be investigated. The fallopian tube stroma in mice, for instance, has been shown to be capable of giving rise to metastatic HGSC, which faithfully recapitulates the clinical behavior and molecular aspect of human HGSC. Elucidating the precise cell(s) of origin of HGSC will be critical for improving the early detection and prevention of ovarian cancer, ultimately reducing ovarian cancer mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
BRCA1 and BRCA2: different roles in a common pathway of genome protection
Roy, R., Chun, J., & Powell, S. N. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3181 · Cited by 1,469
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. C., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3144 · Cited by 1,464
Self-citationNikiforov, Y. E., Seethala, R. R., Tallini, G., Baloch, Z. W., Basolo, F., Thompson, L. D. R., Barletta, J. A., Wenig, B. M., Al Ghuzlan, A., Kakudo, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0386 · Cited by 1,404
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Self-citationEffect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206809 · Cited by 1,367
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Self-citationBuys, S. S. (2011) · JAMA · doi:10.1001/jama.2011.766 · Cited by 1,323
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048 · cited 2×
“By far, the largest screening trial of ovarian cancer has been a randomized clinical trial from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) [53], in which a total of 202,638 postmenopausal women ages 50 to 74 had been followed for a median of 11.1 years and evaluated for ovarian cancer…”
BackgroundInfluentialOvarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0422 · Cited by 1,046
The biology of infertility: research advances and clinical challenges
Matzuk, M. M., & Lamb, D. J. (2008) · Nature Medicine · doi:10.1038/nm.f.1895 · Cited by 951
Rebbeck, T. R., Kauff, N. D., & Domchek, S. M. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn442 · Cited by 939
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
The Mammalian Ovary from Genesis to Revelation
Edson, M. A., Nagaraja, A. K., & Matzuk, M. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0012 · Cited by 820
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ahmed, A. A., Etemadmoghadam, D., Temple, J., Lynch, A. G., Riad, M., Sharma, R., Stewart, C., Fereday, S., Caldas, C., deFazio, A., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2696 · Cited by 787
Ductal Carcinoma in Situ of the Breast
Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C., & Kaelin, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031301 · Cited by 759
High grade serous ovarian carcinomas originate in the fallopian tube
Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 759
Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer
Merritt, W. M., Lin, Y. G., Han, L. Y., Kamat, A. A., Spannuth, W. A., Schmandt, R., Urbauer, D., Pennacchio, L. A., Cheng, J.-F., Nick, A. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803785 · Cited by 712
Intraovarian Control of Early Folliculogenesis
Hsueh, A. J. W., Kawamura, K., Cheng, Y., & Fauser, B. C. J. M. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1020 · Cited by 702
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
Welch, H. G., Prorok, P. C., O’Malley, A. J., & Kramer, B. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600249 · Cited by 699
Cho, K. R., & Shih, I.-M. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092246 · Cited by 694
Mavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., Rosen, B., Maehle, L., Ghadirian, P., Cybulski, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.2820 · Cited by 664
Parker, W. H., Broder, M. S., Chang, E., Feskanich, D., Farquhar, C., Liu, Z., Shoupe, D., Berek, J. S., Hankinson, S., & Manson, J. E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a11c64 · Cited by 640
Inpatient hysterectomy surveillance in the United States, 2000-2004
Whiteman, M. K., Hillis, S. D., Jamieson, D. J., Morrow, B., Podgornik, M. N., Brett, K. M., & Marchbanks, P. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.05.039 · Cited by 639
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.10.013 · Cited by 596
Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., Isaacs, C., Evans, D. G., Lynch, H., Eeles, R. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9626 · Cited by 589
Ovarian Cancer: Screening, Treatment, and Follow-up
Seltzer, V. (1995) · JAMA · doi:10.1001/jama.1995.03520300065039 · Cited by 580
The ovary: basic biology and clinical implications
Richards, J. S., & Pangas, S. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41350 · Cited by 561
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
Seidman, J. D., Horkayne-Szakaly, I., Haiba, M., Boice, C. R., Kurman, R. J., & Ronnett, B. M. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101080.35393.16 · Cited by 554
Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
Peres, L. C., Cushing-Haugen, K. L., Köbel, M., Harris, H. R., Berchuck, A., Rossing, M. A., Schildkraut, J. M., & Doherty, J. A. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy071 · Cited by 554
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Crum, C. P., Drapkin, R., Miron, A., Ince, T. A., Muto, M., Kindelberger, D. W., & Lee, Y. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328011a21f · Cited by 512
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Esserman, L. J., Thompson, I. M., Reid, B., Nelson, P., Ransohoff, D. F., Welch, H. G., Hwang, S., Berry, D. A., Kinzler, K. W., Black, W. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70598-9 · Cited by 501
Ovarian antral folliculogenesis during the human menstrual cycle: A review
Baerwald, A. R., Adams, G. P., & Pierson, R. A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr039 · Cited by 487
Callahan, M. J., Crum, C. P., Medeiros, F., Kindelberger, D. W., Elvin, J. A., Garber, J. E., Feltmate, C. M., Berkowitz, R. S., & Muto, M. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2622 · Cited by 485
Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement
Esserman, L. J., Thompson, I. M., & Reid, B. (2013) · JAMA · doi:10.1001/jama.2013.108415 · Cited by 467
Kurman, R. J., & Shih, I.-M. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318161e4f5 · Cited by 460
The genesis and evolution of high-grade serous ovarian cancer
Bowtell, D. D. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2946 · Cited by 445
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., Weber, B., Rebbeck, T., Neuhausen, S. L., Ghadirian, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7138 · Cited by 443
Ovarian Cancer Risk After Salpingectomy: A Nationwide Population-Based Study
Falconer, H., Yin, L., Gronberg, H., & Altman, D. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju410 · Cited by 436
Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies
Nielsen, M., Thomsen, J., Primdahl, S., Dyreborg, U., & Andersen, J. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.296 · Cited by 418
Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
Przybycin, C. G., Kurman, R. J., Ronnett, B. M., Shih, I.-M., & Vang, R. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181ef7b16 · Cited by 410
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Kim, J., Coffey, D. M., Creighton, C. J., Yu, Z., Hawkins, S. M., & Matzuk, M. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117135109 · Cited by 398
Self-citationOrigins and molecular pathology of ovarian cancer
Bell, D. A. (2005) · Modern Pathology · doi:10.1016/s0893-3952(22)04456-8 · Cited by 387
Kuhn, E., Kurman, R. J., Vang, R., Sehdev, A. S., Han, G., Soslow, R., Wang, T., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3023 · Cited by 387
Finch, A., Shaw, P., Rosen, B., Murphy, J., Narod, S. A., & Colgan, T. J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.065 · Cited by 375
Powell, C. B., Kenley, E., Chen, L.-M., Crawford, B., McLennan, J., Zaloudek, C., Komaromy, M., Beattie, M., & Ziegler, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.109 · Cited by 372
The cell of origin of ovarian epithelial tumours
Dubeau, L. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70308-5 · Cited by 363
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
Precursor lesions of ovarian epithelial malignancy
Feeley, K. M., & Wells, M. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01042.x · Cited by 351
Henderson, J. T., Webber, E. M., & Sawaya, G. F. (2018) · JAMA · doi:10.1001/jama.2017.21421 · Cited by 348
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Flesken-Nikitin, A., Hwang, C.-I., Cheng, C.-Y., Michurina, T. V., Enikolopov, G., & Nikitin, A. Y. (2013) · Nature · doi:10.1038/nature11979 · Cited by 347
Carlson, J. W., Miron, A., Jarboe, E. A., Parast, M. M., Hirsch, M. S., Lee, Y., Muto, M. G., Kindelberger, D., & Crum, C. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4814 · Cited by 347
Metcalfe, K. A., Birenbaum‐Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., Ghadirian, P., Foulkes, W. D., Klijn, J., Friedman, E., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23340 · Cited by 342
Lessons from BRCA: the Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
Crum, C. P., Drapkin, R., Kindelberger, D., Medeiros, F., Miron, A., & Lee, Y. (2007) · Clinical Medicine & Research · doi:10.3121/cmr.2007.702 · Cited by 342
Domchek, S. M., Friebel, T. M., Neuhausen, S. L., Wagner, T., Evans, G., Isaacs, C., Garber, J. E., Daly, M. B., Eeles, R., Matloff, E., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70585-x · Cited by 327
Colgan, T. J., Murphy, J., Cole, D. E. C., Narod, S., & Rosen, B. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200110000-00009 · Cited by 327
Flesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 315
Pathogenesis and heterogeneity of ovarian cancer
Kroeger, P. T., & Drapkin, R. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000340 · Cited by 314
Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.016 · Cited by 313
Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Xiang, H., Harris, S. S., Vanderhyden, B. C., & Hamilton, T. C. (2003) · PubMed · Cited by 310
Cheng, W., Liu, J., Yoshida, H., Rosen, D., & Naora, H. (2005) · Nature Medicine · doi:10.1038/nm1230 · Cited by 305
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Karnezis, A. N., Cho, K. R., Gilks, C. B., Pearce, C. L., & Huntsman, D. G. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.113 · Cited by 300
Lancaster, J. M., Powell, C. B., Chen, L.-M., & Richardson, D. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.09.009 · Cited by 298
Folkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 293
Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women
Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., & Paley, P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6779 · Cited by 292
Colombo, N., Peiretti, M., Garbi, A., Carinelli, S., Marini, C., & Sessa, C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds223 · Cited by 290
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Press, J. Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S. E., Blood, K. A., Smith, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-17 · Cited by 287
A randomized study of screening for ovarian cancer: a multicenter study in Japan
KOBAYASHI, H., YAMADA, Y., SADO, T., SAKATA, M., YOSHIDA, S., KAWAGUCHI, R., KANAYAMA, S., SHIGETOMI, H., HARUTA, S., TSUJI, Y., et al. (2008) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01035.x · Cited by 276
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Pathology of ovarian cancer precursors
Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 264
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Gougeon, A. (2010) · Annales d'Endocrinologie · doi:10.1016/j.ando.2010.02.021 · Cited by 257
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Rojas, V., Hirshfield, K., Ganesan, S., & Rodriguez-Rodriguez, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122113 · Cited by 254
The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer
Hartmann, L. C., & Lindor, N. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1503523 · Cited by 253
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
Walker, J. L., Powell, C. B., Chen, L., Carter, J., Bae Jump, V. L., Parker, L. P., Borowsky, M. E., & Gibb, R. K. (2015) · Cancer · doi:10.1002/cncr.29321 · Cited by 241
Eckert, M. A., Pan, S., Hernandez, K. M., Loth, R. M., Andrade, J., Volchenboum, S. L., Faber, P., Montag, A., Lastra, R., Peter, M. E., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0607 · Cited by 216
Madalinska, J. B., van Beurden, M., Bleiker, E. M. A., Valdimarsdottir, H. B., Hollenstein, J., Massuger, L. F., Gaarenstroom, K. N., Mourits, M. J. E., Verheijen, R. H. M., van Dorst, E. B. L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1896 · Cited by 214
Heemskerk-Gerritsen, B. A. M., Seynaeve, C., van Asperen, C. J., Ausems, M. G. E. M., Collée, J. M., van Doorn, H. C., Gomez Garcia, E. B., Kets, C. M., van Leeuwen, F. E., Meijers-Heijboer, H. E. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv033 · Cited by 206
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Kotsopoulos, J., Huzarski, T., Gronwald, J., Singer, C. F., Moller, P., Lynch, H. T., Armel, S., Karlan, B., Foulkes, W. D., Neuhausen, S. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw177 · Cited by 197
Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002296 · Cited by 193
Molecular Evidence Linking Primary Cancer of the Fallopian Tube to BRCA1 Germline Mutations
Zweemer, R. P., van Diest, P. J., Verheijen, R. H. M., Ryan, A., Gille, J. J. P., Sijmons, R. H., Jacobs, I. J., Menko, F. H., & Kenemans, P. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5623 · Cited by 191
Paley, P. J., Swisher, E. M., Garcia, R. L., Agoff, S. N., Greer, B. E., Peters, K. L., & Goff, B. A. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2000.6071 · Cited by 189
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention
Nezhat, F. R., Apostol, R., Nezhat, C., & Pejovic, T. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.03.044 · Cited by 182
Visvanathan, K., Vang, R., Shaw, P., Gross, A., Soslow, R., Parkash, V., Shih, I.-M., & Kurman, R. J. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31822f58bc · Cited by 177
Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers
Powell, C. B., Chen, L.-M., McLennan, J., Crawford, B., Zaloudek, C., Rabban, J. T., Moore, D. H., & Ziegler, J. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31821bc7e3 · Cited by 169
The Menstrual Cycle: Basic Biology
Hawkins, S. M., & Matzuk, M. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.018 · Cited by 168
Precursors and pathogenesis of ovarian carcinoma
Lim, D. Y., & Oliva, E. (2013) · Pathology · doi:10.1097/pat.0b013e32835f2264 · Cited by 166
Population-based screening for cancer: hope and hype
Shieh, Y., Eklund, M., Sawaya, G. F., Black, W. C., Kramer, B. S., & Esserman, L. J. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.50 · Cited by 166
Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers
Kwon, J. S., Tinker, A., Pansegrau, G., McAlpine, J., Housty, M., McCullum, M., & Gilks, C. B. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182783c2f · Cited by 161
Öktem, Ö., & Oktay, K. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1434.009 · Cited by 159
Gilbert, L., Basso, O., Sampalis, J. S., Karp, I., Martins, C., Feng, J., Piedimonte, S., Quintal, L., Ramanakumar, A. V., TAKEFMAN, J. E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70333-3 · Cited by 155
Seltzer, V., Drukker, B. H., Gillespie, B. W., Gossfeld, L. M., Grigsby, P. W., Harvey, H. A., Hendricks, C. B., Hummel, S., Makuch, R. W., Monaco, G. P., et al. (1995) · JAMA · doi:10.1001/jama.273.6.491 · Cited by 154
Self-citationThe Origin of Ovarian Carcinomas: A Unifying Hypothesis
Auersperg, N. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181f45f3e · Cited by 150
Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status
Manchanda, R., Abdelraheim, A. R., Johnson, M., Rosenthal, A. N., Benjamin, E. O., Brunell, C., Burnell, M., Side, L. E., Gessler, S., Sarıdoğan, E., et al. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.02920.x · Cited by 148
Sherman‐Baust, C. A., Kuhn, E., Valle, B. L., Shih, I., Kurman, R. J., Wang, T., Amano, T., Ko, M. S. H., Miyoshi, I., Araki, Y., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4353 · Cited by 147
BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis
Piek, J. M. J., Verheijen, R. H. M., Kenemans, P., Massuger, L. F. A. G., Bulten, H., & van Diest, P. J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00365-2 · Cited by 147
Biology of Epithelial Ovarian Cancer: Implications for Screening Women at High Genetic Risk
Hogg, R. J., & Friedlander, M. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.179 · Cited by 145
Sherman, M. E., PIEDMONTE, M. R., Mai, P. L., Ioffe, O. B., Ronnett, B. M., Le, L. V., Ivanov, I., Bell, M. C., Blank, S. V., DiSilvestro, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1987 · Cited by 138
Lu, K. H., Skates, S. J., Hernandez, M. A., Bedi, D. G., Bevers, T. B., Leeds, L. J., Moore, R. G., Granai, C. O., Harris, S., Newland, W., et al. (2013) · Cancer · doi:10.1002/cncr.28183 · Cited by 136
Self-citationKramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P., & Greene, M. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9199 · Cited by 135
Carcangiu, M. L., Peissel, B., Pasini, B., Spatti, G., Radice, P., & Manoukian, S. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000202161.80739.ac · Cited by 131
Lessard-Anderson, C. R., Handlogten, K. S., Molitor, R. J., Dowdy, S. C., Cliby, W. A., Weaver, A. L., Sauver, J. L. S., & Bakkum-Gamez, J. N. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.005 · Cited by 130
Autier, P., Boniol, M., Koechlin, A., Pizot, C., & Boniol, M. (2017) · BMJ · doi:10.1136/bmj.j5224 · Cited by 129
Salvador, S., Rempel, A., Soslow, R. A., Gilks, C. B., Huntsman, D. D., & Miller, D. M. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.05.010 · Cited by 128
The role of the fallopian tube in ovarian cancer.
Tone, A. A., Salvador, S., Finlayson, S. J., Tinker, A. V., Kwon, J. S., Lee, C., Cohen, T., Ehlen, T., Lee, M. H., Carey, M. S., et al. (2012) · PubMed · Cited by 123
Szabova, L., Yin, C., Bupp, S., Guerin, T. M., Schlomer, J. J., Householder, D. B., Baran, M. L., Yi, M., Song, Y., Sun, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3834 · Cited by 122
Stromal-to-Epithelial Transition during Postpartum Endometrial Regeneration
Huang, C.-C., Orvis, G. D., Wang, Y., & Behringer, R. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044285 · Cited by 120
Reitsma, W., de Bock, G. H., Oosterwijk, J. C., Bart, J., Hollema, H., & Mourits, M. J. E. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.021 · Cited by 119
Russo, A. D., Calò, V., Bruno, L., Rizzo, S., Bazan, V., & Fede, G. D. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.06.003 · Cited by 118
Breast Cancer Screening in Denmark
Jørgensen, K. J., Gøtzsche, P. C., Kalager, M., & Zahl, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-0270 · Cited by 118
Harmsen, M. G., Jong, M. A.-D., Hoogerbrugge, N., Maas, A. H. E. M., Prins, J. B., Bulten, J., Teerenstra, S., Adang, E., Piek, J. M. J., van Doorn, H. C., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1597-y · Cited by 117
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates
Gurung, A., Hung, T., Morin, J., & Gilks, C. B. (2012) · Histopathology · doi:10.1111/his.12033 · Cited by 117
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective
Jarboe, E. A., Folkins, A. K., Drapkin, R., Ince, T. A., Agoston, E. S., & Crum, C. P. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03408.x · Cited by 115
Bilateral Oophorectomy versus Ovarian Conservation: Effects on Long-term Women's Health
Parker, W. H. (2010) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.12.016 · Cited by 111
Evidence for a Dualistic Model of High-grade Serous Carcinoma
Howitt, B. E., Hanamornroongruang, S., Lin, D. I., Conner, J. E., Schulte, S., Horowitz, N. S., Crum, C. P., & Meserve, E. E. K. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000369 · Cited by 111
Tang, S., Onuma, K., Deb, P., Wang, E., Lytwyn, A., Sur, M., & Daya, D. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31822ea955 · Cited by 107
Rabban, J. T., Garg, K., Crawford, B., Chen, L.-M., & Zaloudek, C. J. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000199 · Cited by 104
Greene, M. H., Piedmonte, M., Alberts, D., Gail, M. H., Hensley, M. L., Miner, Z., Mai, P. L., Loud, J. T., Rodriguez, G. C., Basil, J., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2703 · Cited by 103
The post-reproductive Fallopian tube: better removed?
Dietl, J., Wischhusen, J., & Häusler, S. F. (2011) · Human Reproduction · doi:10.1093/humrep/der274 · Cited by 100
Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers
Beattie, M. S., Crawford, B., Lin, F., Vittinghoff, E., & Ziegler, J. L. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2008.0067 · Cited by 99
High‐grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease
Zhai, Y., WU, R. T., Kuick, R. D., Sessine, M. S., Schulman, S., Green, M., Fearon, E. R., & Cho, K. R. (2017) · The Journal of Pathology · doi:10.1002/path.4927 · Cited by 99
Powell, C. B., Swisher, E. M., Cass, I. A., McLennan, J., Norquist, B. M., Garcia, R. L., Lester, J., Karlan, B. Y., & Chen, L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.029 · Cited by 95
Ovarian sex cord-stromal tumours: an update in recent molecular advances
Lim, D. G. S., & Oliva, E. (2017) · Pathology · doi:10.1016/j.pathol.2017.10.008 · Cited by 93
Peritoneal Lavage Cytology: An Assessment of Its Value during Prophylactic Oophorectomy
Colgan, T. J., Boerner, S. L., Murphy, J., Cole, D. E. C., Narod, S. A., & Rosen, B. P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6638 · Cited by 92
Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective
Jarboe, E. A., Folkins, A. K., Drapkin, R., Ince, T. A., Agoston, E. S., & Crum, C. P. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02938.x · Cited by 92
Jarboe, E. A., Miron, A., Carlson, J. W., Hirsch, M. S., Kindelberger, D. W., Mutter, G. L., Crum, C. P., & Nucci, M. R. (2009) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181934390 · Cited by 91
The Ovary Is an Alternative Site of Origin for High-Grade Serous Ovarian Cancer in Mice
Kim, J., Coffey, D. M., Ma, L., & Matzuk, M. M. (2015) · Endocrinology · doi:10.1210/en.2014-1977 · Cited by 85
Self-citationFan, H., Liu, Z., Paquet, M., Wang, J., Lydon, J. P., DeMayo, F. J., & Richards, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3363 · Cited by 80
Tanwar, P. S., Mohapatra, G., Chiang, S., Engler, D. A., Zhang, L., Kaneko-Tarui, T., Ohguchi, Y., Birrer, M. J., & Teixeira, J. M. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt357 · Cited by 76
BRCA and Early Events in the Development of Serous Ovarian Cancer
George, S. H. L., & Shaw, P. H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00005 · Cited by 75
WU, R. T., Zhai, Y., Kuick, R. D., Karnezis, A. N., Garcia, P. E., Naseem, A. F., Hu, T. C., Fearon, E. R., & Cho, K. R. (2016) · The Journal of Pathology · doi:10.1002/path.4783 · Cited by 75
Chen, F., Gaitskell, K. L., Garcia, M., Albukhari, A., Tsaltas, J., & Ahmed, A. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14543 · Cited by 75
Crum, C. P., Herfs, M. F., Ning, G., Bijron, J. G., Howitt, B. E., Jimenez, C. A., Hanamornroongruang, S., McKeon, F., & Xian, W. (2013) · The Journal of Pathology · doi:10.1002/path.4263 · Cited by 71
Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies
Boussios, S., Zarkavelis, G., Seraj, E., Zerdes, I., Tatsi, K., & Pentheroudakis, G. E. (2016) · Anticancer Research · doi:10.21873/anticanres.11072 · Cited by 71
High Rates of Occult Fallopian Tube Cancer Diagnosed at Prophylactic Bilateral Salpingo-Oophorectomy
Hirst, J. E., Gard, G. B., McIlroy, K., Nevell, D. F., & Field, M. J. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a1b5dc · Cited by 67
The molecular pathology of ovarian serous borderline tumors
Malpica, A. L., & Wong, K. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw089 · Cited by 67
Challenging and Complex Decisions in the Management of the BRCA Mutation Carrier
Stan, D. L., Shuster, L. T., Wick, M. J., Swanson, C. L., Pruthi, S., & Bakkum-Gamez, J. N. (2013) · Journal of Women s Health · doi:10.1089/jwh.2013.4407 · Cited by 66
Yates, M. S., Meyer, L. A., Deavers, M. T., Daniels, M. S., Keeler, E. R., Mok, S. C., Gershenson, D. M., & Lu, K. H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0266 · Cited by 64
Genetics and genomics of ovarian sex cord‐stromal tumors
Fuller, P. J., Leung, D. T. H., & Chu, S. (2016) · Clinical Genetics · doi:10.1111/cge.12917 · Cited by 64
Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations
Schmeler, K. M., Sun, C. C., Bodurka, D. C., White, K. G., Soliman, P. T., Uyei, A. R., Erlichman, J., Arun, B., Daniels, M. S., Rimes, S. A., et al. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000228959.30577.13 · Cited by 62
Clark-Knowles, K. V., Senterman, M. K., Collins, O. M., & Vanderhyden, B. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008534 · Cited by 62
Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
Klotz, D. M., & Wimberger, P. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4529-z · Cited by 62
The relationship between local recurrence and death in early-stage breast cancer
Sopik, V., Nofech‐Mozes, S., Sun, P., & Narod, S. A. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3666-y · Cited by 57
Ren, Y. A., Mullany, L. K., Liu, Z., Herron, A. J., Wong, K., & Richards, J. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1046 · Cited by 54
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53
Quinn, B. A., Brake, T., Xiang, H., Baxter-Jones, K., Litwin, S., Ellenson, L. H., & Connolly, D. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008404 · Cited by 46
Management of Malignant Ovarian Germ Cell Tumors
Parkinson, C., Hatcher, H. M., & Ajithkumar, T. (2011) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318234ede9 · Cited by 44
McCluggage, W. G., Hirschowitz, L., Gilks, C. B., Wilkinson, N. S., & Singh, N. (2016) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000336 · Cited by 42
Scott, M., & McCluggage, W. G. (2006) · PubMed · doi:10.14670/hh-21.81 · Cited by 40
New Insights Into the Pathogenesis of Ovarian Carcinoma: Time to Rethink Ovarian Cancer Screening
Chan, A. M. Y., Gilks, C. B., Kwon, J. S., & Tinker, A. V. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318269b8b1 · Cited by 39
Lee, Y.-J., Lee, S., Kim, K.-R., Jung, K. H., Lee, J. W., & Kim, Y. (2016) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e3 · Cited by 32
Thaye, E. D., de Vijver, K. K. V., der Meulen, J. V., Taminau, J., Wagemans, G., Denys, H. G., Dorpe, J. V., Berx, G., Ceelen, W. P., Bocxlaer, J. V., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63738-6 · Cited by 32
Cass, I. A., Walts, A. E., Barbuto, D. A., Lester, J., & Karlan, B. Y. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.084 · Cited by 31
Seidman, J. D., Krishnan, J., Yemelyanova, A. V., & VANG, R. S. (2015) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000267 · Cited by 30
Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing
Kram, V., Peretz, T., & Sagi, M. (2006) · Familial Cancer · doi:10.1007/s10689-006-0002-z · Cited by 28
Accepting the existence of breast cancer overdiagnosis
Brawley, O. W. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2850 · Cited by 26
Precious GEMMs: emergence of faithful models for ovarian cancer research
Stückelberger, S., & Drapkin, R. (2018) · The Journal of Pathology · doi:10.1002/path.5065 · Cited by 26
A mouse model for endometrioid ovarian cancer arising from the distal oviduct
van der Horst, P. H., van der Zee, M., Heijmans‐Antonissen, C., Jia, Y., DeMayo, F. J., Lydon, J. P., van Deurzen, C. H. M., Ewing, P. C., Burger, C. W., & Blok, L. J. (2014) · International Journal of Cancer · doi:10.1002/ijc.28746 · Cited by 24
Ovarian Epithelial Inclusion Cysts in Chronically Superovulated CD1 and Smad2 Dominant-Negative Mice
Burdette, J. E., Oliver, R. M., Ulyanov, V. O., Kilen, S. M., Mayo, K. E., & Woodruff, T. K. (2007) · Endocrinology · doi:10.1210/en.2007-0030 · Cited by 22
Koç, N., Ayas, S., & Uygur, L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.089 · Cited by 13
Whence epithelial ovarian carcinoma?
Boyd, J. A. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.03.016 · Cited by 10
(2000) · doi:10.1002/1097-0142(20000715)89:2
Cited by
Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death
Tesfay, L., Paul, B. T., Konstorum, A., Deng, Z., Cox, A. O., Lee, J., Furdui, C. M., Hegde, P., Torti, F. M., & Torti, S. V. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0369 · Cited by 551
PARP inhibitors in the Management of Ovarian Cancer: ASCO guideline
Tew, W. P., Lacchetti, C., Ellis, A., Maxian, K., Banerjee, S., Bookman, M., Jones, M. B., Lee, J.-M., Lheureux, S., Liu, J. F., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01924 · Cited by 315
The Origin of Ovarian Cancer Species and Precancerous Landscape
Shih, I.-M., Wang, Y., & Wang, T.-L. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.09.006 · Cited by 255
Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models
Maenhoudt, N., Defraye, C., Boretto, M., Jan, Z., Heremans, R., Boeckx, B., Hermans, F., Arijs, I., Cox, B., Van Nieuwenhuysen, E., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.03.004 · Cited by 186
McDermott, J. E., Arshad, O. A., Petyuk, V. A., Fu, Y., Gritsenko, M. A., Clauss, T. R., Moore, R. J., Schepmoes, A. A., Zhao, R., Monroe, M. E., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100004 · Cited by 97
Metadata
- Authors
- Kim, J., Park, E., Kim, O., Schilder, J., Coffey, D., Cho, C.-H., & Bast, R.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-11-12
- Volume
- 10
- Issue
- 11
- Pages
- 433
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2901666999
- Cited by
- 264
- References
- 180
- FWCI
- 21.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.